Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

MORRISVILLE, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, today announced its financial results for the second quarter ended June 30, 2025. The company will also host a webcast at 8:30 a.m. Eastern Time on August 12, 2025, to review financial performance and provide a corporate update.

Source: https://www.globenewswire.com/news-release/2025/08/12/3131515/0/en/Liquidia-Corporation-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html